Skip to main content
Clinical Trials/ACTRN12620000220965
ACTRN12620000220965Completed未知

The effect of medicinal cannabis oil on sleep in adults with insomnia investigated in a randomised double-blind placebo-controlled cross-over trial of 6 weeks duration

AProf Dr Karin Ried0 sites30 target enrollmentStarted: February 24, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
25 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • Insomnia - measured by insomnia severity index > 7
  • - having one or more of the following symptoms:
  • - Difficulty falling asleep
  • - Waking up often during the night and/or
  • - Having trouble going back to sleep
  • & Willing not to drive a vehicle during 6 weeks of the study

Exclusion Criteria

  • Subjects are not pregnant or diagnosed with cancer, unstable cardiac disease, psychotic disorder, schizophrenia, manic episode, seizure disorder, glaucoma, or urinary retention.
  • Subjects are not shiftworkers.
  • Subjects are not taking anti-depressants including tricyclic anti-depressant, monoamine oxidase inhibitors, or benzodiazepines.
  • Subjects known to have hypersensitivity to cannabinoids.
  • During the study, subjects will be required to avoid taking any other sleep remedies both natural and pharmaceuticals.

Investigators

Sponsor
AProf Dr Karin Ried

Similar Trials